Insider buying last 90 days
No open-market insider purchases were filed for MMSI in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every MMSI insider filing, plotted on the chart in Gekko.Open MMSI in Gekko
NASDAQ: MMSI
Merit Medical Systems (MMSI) Stock Analysis & Forecast
Sep 28 close
$87.00−0.50 (−0.6%)
Gekko Brief
AI summaryThis week's coverage frames Merit Medical Systems against peer Bausch + Lomb and highlights its financial standing, with analysts largely positive on the stock. One analysis points to a consensus target price of $101.45, described as suggesting notable upside, alongside a $5.1 billion market cap and figures citing 9.50% revenue growth and EPS of 2.43. The commentary centers on comparative valuation and analyst sentiment rather than new company disclosures this week.
MMSI closes at $87.00, down 0.6%, sitting above both its 50-day average of $86.29 and its 200-day average of $76.73, with the shorter average above the longer one. The GekkoIndex reads 57.4, placing it in the Neutral zone, after slipping 5.1 points over the past five sessions. The stock trades 13.9% below its Gekko Fair Value of $100.99, a gap that has held wider than 5%. Over the past year the stock has returned 8.7%, with a six-month gain of 26.6% and a one-month decline of 2.8%.
The next earnings report falls on 29 October 2026, after the close, 30 days out and beyond a typical 20-trading-day holding window; the prior quarter saw EPS of $1.09 against an $0.85 estimate and a 5.2% reaction. No insider, Congress, or unusual options activity appears in the current windows. Seasonality data show the next 20 trading days averaging a 1.6% gain over five years, rising in 2 of those years, with analyst consensus among 10 firms showing 8 buys and 2 holds.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Merit Medical Systems price vs fair value
Close $87.00200-day averageGekko Fair Value $100.99
Merit Medical Systems quick facts
- Market cap
- $5.19B
- P/E ratio
- 35.9
- Forward P/E
- 18.9
- EPS, TTM
- $2.43
- Revenue, TTM
- $1.58B
- Profit margin
- 9.2%
- Dividend yield
- —
- Beta
- 0.49
- Volume
- 527,189 avg 575,534
- 1-year return
- +8.7%
- Typical daily move
- ±2%
- Typical 20-day move
- ±5.4%
- 50-day average
- $86.29
- 200-day average
- $76.73
- Next earnings
- Oct 29 after close
- Shares outstanding
- 59.71M
Merit Medical Systems swing-trade checklist
Merit Medical Systems scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
- Trendsupportive
Above 50 and 200-day
Close $87.00 is above the 50-day ($86.29) and 200-day ($76.73) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
57.4, Neutral
Reading 57.4 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
13.9% below
Price is 13.9% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 30 days
Next report Oct 29, 2026, 30 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
+1.6% on average
From this point in the calendar, the next 20 trading days averaged +1.6% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Merit Medical Systems stock chart and price history
Merit Medical Systems closed at $87.00 on Sep 28, 2026, +8.7% over the past year, inside a 52-week range of $59.74 to $94.75.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −2.8%
- 3 months
- +24.1%
- 6 months
- +26.6%
- 1 year
- +8.7%
The full MMSI chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open MMSI in Gekko
Follow Merit Medical Systems through every session
Put MMSI on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track MMSI in GekkoFree for 7 days. No credit card required.
Merit Medical Systems GekkoIndex: the smart money zone
Merit Medical Systems’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 57.4, in the Neutral zone, down 5.1 points over five sessions.
57.4Neutral
Down 5.1 points over five sessions, from the Accumulation zone.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 42 | −0.3% | −0.2% | ||
| Accumulation | 219 | +0.4% | +1.8% | ||
| Neutral (current zone) | 372 | 0.0% | +0.1% | ||
| Distribution | 30 | −0.1% | −0.9% | ||
| Selling | 9 | Too few readings yet | |||
Average MMSI share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the MMSI price, zone by zone.Track MMSI in Gekko
Is Merit Medical Systems stock overvalued? Gekko Fair Value
Merit Medical Systems trades 13.9% below Gekko Fair Value of $100.99, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Merit Medical Systems shares are worth, recalculated every trading day.
$100.99
Gekko Fair Value, Sep 26, 2026
13.9% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open MMSI in Gekko
Merit Medical Systems insider and Congress trading
No open-market insider purchases were filed for Merit Medical Systems, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in MMSI were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for MMSI, plotted on the chart in Gekko.Open MMSI in Gekko
Merit Medical Systems earnings: next date and track record
Merit Medical Systems reports on Oct 29, 2026, after the close (30 days away), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Oct 29, 2026
Expected after the close, 30 days away
- EPS estimate
- $1.04
- Revenue estimate
- $410.4M
8 of 8reports beat the EPS estimate
±3.7%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 30, 2026 AI summary
- What they said
- Merit Medical reported a strong Q2 2026 with total revenue of $418.8 million (up 10% GAAP, 9% constant currency) driven by 9% organic growth and contributions from recent acquisitions (Biolife and C2 CryoBalloon). Management highlighted the strongest quarterly organic growth in three years, a 142 bps increase in non-GAAP operating margin to 22.6%, an 18% increase in non-GAAP EPS, and nearly $52 million of free cash flow, including tariff-refund benefits. Growth was broad-based across Foundational and Therapeutic product categories, with notable strength in Vascular Intervention, Access, Cardiac Therapies, Endoscopy, OEM recovery, and oncology products (SCOUT MD/OneMark). Management emphasized progress on its CGI program and strategic planning for the next multi-year period while continuing tuck-in M&A activity and integrations (C2, View Point, Biolife).
- Guidance
- Q3 revenue growth guidance: 6% to 8% (seasonal step down from Q2). Full-year guidance for 2026 was reiterated/updated in the press release (management expressed confidence in the full-year outlook). Free cash flow target for 2026: ~$200 million (company remains focused on the $200M target for the year). OEM annual growth expectation: mid- to high-single-digits. WRAPSODY revenue target for 2026: $7 million. Management noted no change to China expectations (low single-digit growth) and expects only about $1.5M remaining tariff refund potentially collectible from a third party (timing uncertain).
- Risks flagged
- Tariff uncertainty and Section 122 / USMCA changes; exposure to supply-chain disruptions and raw material availability (Middle East conflict prompting resin purchases); recall-related lost share in renal that will take time to recapture; pricing sensitivity in outpatient settings for products like WRAPSODY; lumpy OEM business and variability in China/VBP dynamics; competitive pressure in certain markets; macro seasonality and physician/patient procedure volume variability.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $1.09 est $0.85 | $418.8M est $405.2M | +5.2% |
| Apr 30, 2026 | $0.94 est $0.83 | $381.9M est $377.6M | −4.4% |
| Feb 24, 2026 | $1.04 est $0.95 | $393.9M est $389.9M | −2.9% |
| Oct 30, 2025 | $0.92 est $0.82 | $384.2M est $388.3M | +7.6% |
| Jul 30, 2025 | $1.01 est $0.86 | $382.5M est $371.5M | +2.4% |
| Apr 24, 2025 | $0.86 est $0.75 | $355.4M est $352.5M | +0.9% |
| Feb 25, 2025 | $0.93 est $0.83 | $355.2M est $351.5M | −3.0% |
| Oct 30, 2024 | $0.86 est $0.80 | $339.8M est $347.0M | +2.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Merit Medical Systems stock forecast and analyst price targets
Analysts’ average 12-month price target for Merit Medical Systems is $101.45, +16.6% from the last close, from 10 firms rating the stock in the last 90 days.
$101.45consensus 12-month target, +16.6% from the last close
Now $87.00Avg $101.45
Low $83High $114
Each firm’s latest rating in the last 90 days: 10 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 18 | Piper Sandler | $106 | +21.8% |
| Aug 11 | BTIG | $105 | +20.7% |
| Aug 4 | J.P. Morgan | $95 | +9.2% |
| Aug 3 | Canaccord Genuity | $94 | +8.0% |
| Jul 31 | Bank of America Securities | — | — |
+0.1%average 20-day move after past Neutral readings
+1.6%average move over the next 20 trading days in the last 5 years
±2%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Merit Medical Systems seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Merit Medical Systems averaged +1.6% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.4% | 2 of 5 |
| Next 10 trading days | −2.3% | 1 of 5 |
| Next 15 trading days | −1.3% | 2 of 5 |
| Next 20 trading days | +1.6% | 2 of 5 |
| Next 30 trading days | +6.5% | 4 of 5 |
For scale, MMSI’s typical 20-trading-day move in either direction is about 5.4%.
Merit Medical Systems market cap and key statistics
Merit Medical Systems’s market cap is $5.19B, with a P/E ratio of 35.9 and revenue of $1.58B over the last twelve months.
Valuation
- Market cap
- $5.19B
- P/E ratio
- 35.9
- Forward P/E
- 18.9
- EPS, TTM
- $2.43
- Gekko Fair Value
- $100.99
Trading
- Volume
- 527,189
- Avg volume, 20 days
- 575,534
- 52-week high
- $94.75
- 52-week low
- $59.74
- Shares outstanding
- 59.71M
Financials
- Revenue, TTM
- $1.58B
- Profit margin
- 9.2%
- Return on equity
- 9.2%
- Quarterly earnings growth, YoY
- +20.4%
Risk and income
- Beta
- 0.49
- Typical daily move
- ±2%
- Typical 20-day move
- ±5.4%
Merit Medical Systems stock news this week
2 headlines about Merit Medical Systems from the past week, newest first, each linking to the publisher.
- Financial Survey: Merit Medical Systems (NASDAQ:MMSI) vs. Bausch + Lomb (NYSE:BLCO)Defense World, Sep 24
- Merit Medical Systems, Inc. (MMSI) Stock Analysis: 18.84% Potential Upside Beckons InvestorsDirectorsTalk Interviews, Sep 21
Merit Medical Systems peers
Merit Medical Systems’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Distribution | 23.7% above |
| ABTAbbott Laboratories | Accumulation | 15.0% below |
| DHRDanaher | Distribution | 10.2% above |
| ISRGIntuitive Surgical | Neutral | 17.0% above |
| MDTMedtronic | Accumulation | 24.1% below |
| SYKStryker | Accumulation | 14.1% below |
A peer links to its own page where one exists.
Merit Medical Systems stock FAQ
What is Merit Medical Systems’s market cap?
Merit Medical Systems’s market cap is $5.19B at the Sep 28, 2026 close of $87.00, with 59.71M shares outstanding. The shares trade on a P/E ratio of 35.9.
What is the Merit Medical Systems stock forecast?
The consensus analyst 12-month price target for Merit Medical Systems is $101.45, +16.6% from the last close. Of the 10 firms that rated the stock in the last 90 days, 8 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Merit Medical Systems stock overvalued or undervalued?
On Gekko’s estimate Merit Medical Systems is undervalued: the Sep 28, 2026 close of $87.00 is 13.9% below Gekko Fair Value of $100.99. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Merit Medical Systems report earnings next?
Merit Medical Systems is expected to report on Oct 29, 2026, after the market closes (30 days away). Analysts expect earnings of $1.04 per share on revenue of $410.4M. Merit Medical Systems beat the earnings estimate in 8 of its last 8 reports, moving 3.7% on average across the report.
What is Merit Medical Systems’s 52-week high and low?
Merit Medical Systems’s 52-week high is $94.75 and its 52-week low is $59.74; it closed at $87.00 on Sep 28, 2026, +8.7% over the past year. Over the last five years the shares peaked at $111.45 on Jan 31, 2025.
Is Merit Medical Systems stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, fair value and earnings risk), 2 as mixed (gekkoindex and seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Merit Medical Systems the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.